Concepedia

Teicher Ba

TB

Statistics

Publications

4

Citations

77

H-Index

4

Active since

1992

Affiliations

Eli Lilly (United States)(Current)

Teicher Ba is an author at Eli Lilly (United States) specializing in medicine, oncology, and cancer pharmacology.

Publications per year

1992–2002

4

Publications

4

Antiangiogenic and antitumor effects of a protein kinase C beta inhibitor in human hepatocellular and gastric cancer xenografts.

Teicher Ba, Krishna Menon, Enrique Álvarez et al. · PubMed · 2002 · 35 citations

Medicine, Oncology, Pharmacology +14

Perfluorochemical emulsions: oxygen breathing in radiation sensitization and chemotherapy modulation.

Teicher Ba, Herman Ts · PubMed · 1992 · 18 citations

Medicine, Oncology, Radiation Oncology +17

Differential interactions of Pgp inhibitor thaliblastine with adriamycin, etoposide, taxol and anthrapyrazole CI941 in sensitive and multidrug-resistant human MCF-7 breast cancer cells.

G Chen, Teicher Ba, Eva Frei · PubMed · 1997 · 12 citations

Medicine, Oncology, Pharmacology +14

Cryptophycin 52 and cryptophycin 55 in sequential and simultaneous combination treatment regimens in human tumor xenografts.

Teicher Ba, P Forler, Krishna Menon et al. · PubMed · 2000 · 12 citations

Medicine, Pharmacology, Radiation Oncology +13

1–4 of 4